AlternativeName Voltage-dependentT-typecalciumchannelsubunitα1G
KOValidated KOValidated
Thespecificityofthisantibodyhasbeenvalidatedinaknockout(KO)orknockdown(KD)system.
LyophilizedPowder LyophilizedPowder
Thisproductisfreezedried.Allwatermoleculeshavebeenremoved.
AntigenIncl. AntigenIncl.
ThisantibodyisshippedwithitsantigenFREEofcharge!
Type: Polyclonal
Host: Rabbit
Reactivity: h,m,r
Immunogen- + PeptideMDEEEDGAGAEESGQPRSFTQL(C),correspondingtoaminoacidresidues1-22ofratCACNA1G (Accession O54898).Intracellular,N-terminus.
Accession(Uniprot)Number O54898
GeneID O54898
Peptideconfirmation Confirmedbyaminoacidanalysisandmassspectrometry.
Homology Mouse-identical;human-20/22aminoacidresiduesidentical.
RRID AB_2039779.
Purity Affinitypurifiedonimmobilizedantigen.
Form Lyophilizedpowder.Reconstitutedantibodycontainsphosphatebufferedsaline(PBS),pH7.4,1%BSA,0.05%NaN3 .
Isotype RabbitIgG.
Storagebeforereconstitution Theantibodyshipsasalyophilizedpowderatroomtemperature.Uponarrival,itshouldbestoredat-20°C.
Reconstitution 25µl,50µlor0.2mldoubledistilledwater(DDW),dependingonthesamplesize.
Antibodyconcentrationafterreconstitution 0.8mg/ml.
Storageafterreconstitution Thereconstitutedsolutioncanbestoredat4°Cforupto1week.Forlongerperiods,smallaliquotsshouldbestoredat-20°C.Avoidmultiplefreezingandthawing.Centrifugeallantibodypreparationsbeforeuse(10000xg5min).
Negativecontrolantigenstoragebeforereconstitution Lyophilizedpowdercanbestoredintactatroomtemperaturefor2weeks.Forlongerperiods,itshouldbestoredat-20°C.
Negativecontrolantigenreconstitution 100µldoubledistilledwater(DDW).
Negativecontrolantigenstorageafterreconstitution -20°C.
PreadsorptionControl 1µgpeptideper1µgantibody.
Standardqualitycontrolofeachlot Westernblotanalysis.
Applications: ic,if,ih,wb
Mayalsoworkin: ifc* ,ip*
Westernblot- + Westernblotanalysisofratbrainmembranes:
1. Anti-CACNA1G(CaV 3.1) Antibody (#ACC-021),(1:200). 2.Anti-CACNA1G(CaV 3.1)Antibody,preincubatedwiththenegativecontrolantigen.
Immunohistochemistry- + ExpressionofCACNA1G inratcerebellum
Immunohistochemicalstainingofratcerebellumusing Anti-CACNA1G(CaV 3.1) Antibody (#ACC-021).A.CACNA1G immunoreactivity(green)appearsinthemolecularlayer.B.NuclearstainingusingDAPIasthecounterstain(blue).C.MergedimagesAandB.Mol=molecularlayer.
Humanmyometrium(1:200)(Blanks,A.M. etal. (2007) J.Physiol . 581, 915.).
Immunocytochemistry- + Humanmyometriumcells(1:200)(Blanks,A.M. etal. (2007) J.Physiol . 581, 915.).
References
1.Serrano,J.R.etal. (1999)J.Gen.Physiol. 114, 185. 2.Perez-Reyes,E.(2003)Physiol.Rev. 83, 117. 3.Wain,H.M.etal. (2002)NucleicAcidsRes. 30, 169. 4.Andreasen,D.etal. (2000)Am.J.Physiol. 279, F997. Scientificbackground- + Voltage-dependentCa2+ channelsprovideapathwayforrapidinfluxofCa2+ intocells, whichplaysacrucialroleinbothelectricalandmetabolicsignaling.1
T-typecurrentsaretransducedviachannelproteinsencodedbythreegenesthat composeasubfamilywithintheCaV channelfamily.2-3
TheactivityofT-typechannelscontributestoseveralknownphysiologicalandpathophysiological phenomenaincludingburstfiringinneurons,pacemakingactivityintheheartandsecretionfromendocrinetissues.2 TherearethreeclonedT-typechannelisoforms.
CACNA1G(CaV 3.1)andCACNA1H(CaV 3.2)arewidelydistributedwhereastheexpressionofCACNA1I(CaV 3.3) isrestrictedtothecentralnervoussystem.2
CACNA1GandCACNA1H arealsoexpressedinthekidney,butlittleisknownabouttheirphysiologicalrolethere.
LyophilizedPowder NegativeControlAntigenIncluded
Image&Title: ExpressionofCaV 3.1inmousepelviskidneyjunction. Immunohistochemicalstainingofmousekidneysectionsusing Anti-CACNA1G(CaV 3.1)Antibody (#ACC-021).A.Ca V 3.1(purple)isdetectedinthepelviskidneyjunction(PKJ).B.HCN3staining(green),aMarker ofpacemakercells,isdetectedinthePKJ.C.SamesectionstainedforCa V 3.1(red).D.MergeofBandCpanelsshowshighdegreeofco-localizationbetweenCa V 3.1andHCN3. Adaptedfrom Hurtado,R.etal. (2014)withpermissionof FederationofAmericanSocietiesforExperimentalBIOLOG y. Lastupdate:10/11/2019
Anti-CACNA1G(CaV 3.1)Antibody (#ACC-021)isahighlyspecificantibodydirectedagainstanepitopeoftheratCaV 3.1channel.Theantibody canbeusedinwesternblot,immunocytochemistry,andimmunohistochemistryapplications.IthasbeendesignedtorecognizeCACNA1G fromhuman,rat,andmousesamples.
Forresearchpurposesonly,notforhumanuse
Discovery Antibodies的Cyclin dependant kinase 2 (CDK2) is a serine/threonine protein kinase which controls both G1/S and G2/M transitions. CDKs along with cyclins and CDK inhibitors regulate cell cycle progression. Specific cyclins activate different CDKs; in early G1, CDK2 pairs with cyclin E to promote entry into the S phase before switching to partner with cyclin A to drive the cell through S phase. Once activated CDKs phosphorylate downstream proteins to initiate signalling cascades. CDK2 phosphorylates and inactivates the RB1 (pRb) tumour suppressor family of proteins.CDK的活动受到严格控制。CDK2活性可以被包括P21在内的一系列抑制剂抑制。细胞周期失调和增殖控制的丧失与细胞转化和癌症密切相关。CDK2在DNA损伤反应(DDR)中的细胞周期停滞中也似乎起着积极作用,它的抑制作用会阻碍DDR,并使细胞对电离辐射敏感,从而诱导细胞死亡。该抗体与AlexaFluor®488偶联。AlexaFluor®488是一种流行的鲜绿色荧光染料,具有高pH稳定性。